Regulatory News
Monday, April 25, 2016
UPDATE 1-U.S. FDA panel meets to discuss Sarepta muscular dystrophy drug
April 25 (Reuters) - Hundreds of patients and advocates
packed a hotel ballroom in Hyattsville, Maryland, on Monday to
try to persuade advisers to the U.S. Food and Drug
Administration to support...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment